Literature DB >> 7952547

Longitudinal changes in lung function among asbestos-exposed workers.

D A Schwartz1, C S Davis, J A Merchant, W B Bunn, J R Galvin, D S Van Fossen, C S Dayton, G W Hunninghake.   

Abstract

To prospectively identify the determinants of persistent or accelerated loss of lung function among workers occupationally exposed to asbestos and assess the relative contribution of cigarette smoking, asbestos-induced pleural fibrosis, and specific findings from bronchoalveolar lavage and high resolution CT scans, we examined the determinants of lung function changes in 117 subjects occupationally exposed to asbestos for at least 1 yr in a high exposure setting. A minimum of 20 yr was required between the first exposure to asbestos and entry into the study. Baseline studies included an independent assessment of dyspnea, lung volumes, diffusing capacity of carbon monoxide (DLCO), a chest radiograph, a high resolution CT (HRCT) scan, and bronchoalveolar lavage (BAL). Subjects were observed for an average of 2 yr (range, 0.5 to 4.0 yr), and lung function was measured on at least two separate occasions (mean, 4.1 separate tests). During the period of observation, there was an average 1.5% decrease in the TLC and a 2.5% decrease in the DLCO. In this longitudinal data set, after controlling for age, height, pack-years of cigarette smoking, and follow-up time, persistently lower measures of TLC were independently related to moderate to severe dyspnea (p = 0.005), diffuse pleural thickening (p = 0.007), and higher concentrations of fibronectin in BAL fluid (p = 0.01). Interstitial lung disease either on the chest radiograph or HRCT scan was not independently associated with persistently lower measures of TLC during the period of observation. However, none of the clinical variables we examined were associated with an accelerated decline in TLC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952547     DOI: 10.1164/ajrccm.150.5.7952547

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

Review 1.  Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.

Authors:  Clementina Mesaros; Andrew J Worth; Nathaniel W Snyder; Melpo Christofidou-Solomidou; Anil Vachani; Steven M Albelda; Ian A Blair
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

2.  Macrophage Akt1 Kinase-Mediated Mitophagy Modulates Apoptosis Resistance and Pulmonary Fibrosis.

Authors:  Jennifer L Larson-Casey; Jessy S Deshane; Alan J Ryan; Victor J Thannickal; A Brent Carter
Journal:  Immunity       Date:  2016-02-23       Impact factor: 31.745

3.  Non-malignant consequences of decreasing asbestos exposure in the Brazil chrysotile mines and mills.

Authors:  E Bagatin; J A Neder; L E Nery; M Terra-Filho; J Kavakama; A Castelo; V Capelozzi; A Sette; S Kitamura; M Favero; D C Moreira-Filho; R Tavares; C Peres; M R Becklake
Journal:  Occup Environ Med       Date:  2005-06       Impact factor: 4.402

Review 4.  Ecogenomics of respiratory diseases of public health significance.

Authors:  Stavros Garantziotis; David A Schwartz
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

Review 5.  Systematic review of pleural plaques and lung function.

Authors:  Laura E Kerper; Heather N Lynch; Ke Zu; Ge Tao; Mark J Utell; Julie E Goodman
Journal:  Inhal Toxicol       Date:  2014-12-18       Impact factor: 2.724

6.  Descriptive analysis of the respiratory health status of persons exposed to Libby amphibole asbestos.

Authors:  Charlene A Winters; Wade G Hill; Kimberly Rowse; Brad Black; Sandra W Kuntz; Clarann Weinert
Journal:  BMJ Open       Date:  2012-11-21       Impact factor: 2.692

7.  Non-Malignant Respiratory Illnesses in Association with Occupational Exposure to Asbestos and Other Insulating Materials: Findings from the Alberta Insulator Cohort.

Authors:  Subhabrata Moitra; Ali Farshchi Tabrizi; Kawtar Idrissi Machichi; Samineh Kamravaei; Noushin Miandashti; Linda Henderson; Manali Mukherjee; Fadi Khadour; Muhammad T Naseem; Paige Lacy; Lyle Melenka
Journal:  Int J Environ Res Public Health       Date:  2020-09-28       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.